Navigation Links
Columbia University Medical Center and Rosetta Genomics Announce Columbia University's Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica
Date:4/3/2008

of microRNA. Founded in 2000, the company's integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs. Building on its strong IP position and proprietary platform technologies, Rosetta Genomics is working on the application of these technologies in the development of a full range of microRNA-based diagnostic and therapeutic tools, focusing primarily on cancer and various women's health indications. The company expects that the first microRNA diagnostic tests applying its technology will be launched by licensed clinical laboratories in the United States in 2008.

Forward-Looking Statement Disclaimer

Various statements in this release concerning Rosetta's future expectations, plans and prospects, including without limitation, statements relating to the role of microRNAs in human physiology and disease, the potential of microRNAs in the diagnosis and treatment of disease and the expected timing of submission for approval and launch of diagnostic tests using our microRNA technology constitute forward-looking statements for the purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including risks related to: Rosetta's approach to discover microRNA technology and to work on the application of this technology in the development of novel diagnostics and therapeutic tools, which is unproven and may never lead to marketable products or services; Rosetta's ability to fund and the results of further pre-clinical and clinical trials; Rosetta's ability to obtain, maintain and protect the intellectual property utilized by Rosetta's products; Rosetta's ability to enforce its patents against infringers and to defend its patent portfolio against challenges from third part
'/>"/>

SOURCE Rosetta Genomics Ltd
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
2. Boston University Biomedical Engineers Find Chink in Bacterias Armor
3. Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
4. Potential Breakthrough Cancer Treatment Emerges from MIPS-Funded Clinical Trial Teaming CSA Medical Inc. and University of Maryland Researchers
5. Tezampanel, TorreyPines Therapeutics Lead Compound, Reduced Muscle Spasticity and Rigidity in Preclinical Study Conducted at University of California, San Diego
6. University of Pennsylvania School of Medicine Study Shows Significant Differences in English- and Spanish-speakers Use of Oncology Websites
7. Raydiance Collaborates With Rutgers University and Nations Largest Tissue Bank to Develop Innovative Tissue Processing Approaches
8. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
9. Nobel Laureate Dr. Gunter Blobel to Speak at Florida Atlantic University
10. Beckman Coulter Announces Licensing Agreements for Molecular Tests with National University of Ireland, Galway
11. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... May 22, 2013 Hemoglobin A1C levels ... with Type 2 diabetes, while modest improvements in ... outcomes and can lead to substantial healthcare cost ... International Society for Pharmacoeconomics and Outcomes Research (ISPOR) ... studies, sponsored by Valeritas, makers of the V-Go ...
(Date:5/22/2013)... , May 22, 2013  Generex Biotechnology Corporation ... demonstrating the superiority of the AE37 breast cancer vaccine ... ( www.antigenexpress.com ). The presentations will be made at ... Oncology (ASCO) to be held in Chicago ... The presentation entitled " Booster inoculations of ...
(Date:5/22/2013)...  Flagship Ventures, a leading venture capital and ... today announced the appointment of Stephane ... this role, Mr. Bancel will provide strategic counsel ... addition to working closely with companies in the ... and Chief Executive Officer of Moderna Therapeutics, a ...
Breaking Medicine Technology:Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 2Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 3Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 4Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 5Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 6Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 2Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 3Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 4Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 2Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 3
(Date:5/22/2013)... Angeles, CA (PRWEB) May 22, 2013 Many ... a great deal of pain for a patient if left ... that their pain could be easily fixed through occlusal adjustment. ... teeth, or neck and back pain should have their dentist ... can change the bite and can lead to problems if ...
(Date:5/22/2013)... is available in German . ... Research Foundation) is establishing 11 new Research Training Groups ... decision was made by the relevant Grants Committee in ... awarded to the new programmes for an initial period ... the 11 new Research Training Groups, the Grants Committee ...
(Date:5/22/2013)... Hopkins researchers have developed new guidelines the first ... amount of blood ordered for surgical patients. The recommendations, ... The Johns Hopkins Hospital (JHH), can potentially save the ... patient safety, researchers say. , A report on the ... online in the journal Anesthesiology , suggests millions ...
(Date:5/22/2013)... Ethos Spa Skin and Laser Center , has ... lifestyle of the modern man and woman. All customers have ... whether it is for an anniversary or birthday present, a ... , Clients should know that they have a wide selection ... the Ethos Spa’s website, ranging from abstract artistic drawings to ...
(Date:5/22/2013)... May 22, 2013 Beginning Aug. 22, ... the Conrad Foundation’s Spirit of Innovation Challenge . ... plan competition, free and open to students ages 13 ... Spirit of Innovation Challenge celebrates the life and entrepreneurial ... on the Moon. The program challenges teens to work ...
Breaking Medicine News(10 mins):Health News:Dr. Martin N. Gorman: Make Headaches, Sensitive Teeth and Neck or Back Pain a Thing of the Past 2Health News:DFG establishes 11 new research training groups 2Health News:DFG establishes 11 new research training groups 3Health News:DFG establishes 11 new research training groups 4Health News:DFG establishes 11 new research training groups 5Health News:Johns Hopkins rewrites obsolete blood-ordering rules 2Health News:Johns Hopkins rewrites obsolete blood-ordering rules 3Health News:Ethos Spa Skin And Laser Center Has Launched Their Customizable Gift Certificates 2Health News:Conrad Foundation Announces 2013-2014 Spirit of Innovation Challenge Launch Date 2
... , FRIDAY, Jan. 20 (HealthDay News) -- Rapid ... with an increased risk of asthma symptoms in preschool children, ... infancy might be a critical period for the development of ... Netherlands. They examined data collected from 5,125 children who ...
... non-intubated,patients may be an effective strategy for bridging patients ... Germany. "As waiting times for donor organs continue ... for patients with end-stage lung disease awaiting transplantation," said ... Hannover Medical School in Hannover, Germany. "Our study shows ...
... Shortages of key drugs used to fight infections represent ... risk, according to a review published in Clinical ... anti-infective shortages can substantially alter clinical care and may ... development of new anti-infectives has slowed and the prevalence ...
... , THURSDAY, Jan. 19 (HealthDay News) -- Allowing homeless ... were provided with housing actually decreased their heavy drinking by ... found. The study, published in the Jan. 19 issue ... included residents of a program called project-based Housing First, which ...
... aggressive and spread they are the most deadly. Unfortunately, ... A new imaging platform developed by Lawson Health Research ... insight into just that - the exact moment when ... E-cadherin, are important for the maintenance of normal tissue ...
... With a growing need for family-friendly workplace policies, ... Women & Families, with support from the Rockefeller Foundation, ... to positive economic outcomes for working families, businesses and ... for Women and Work at Rutgers, the State University ...
Cached Medicine News:Health News:Rapid Infant Growth Linked to Asthma in Study 2Health News:Extracorporeal membrane oxygenation as a bridge to lung transplantation 2Health News:Anti-infective drug shortages pose threat to public health and patient care 2Health News:Alcohol OK in Housing for Formerly Homeless, Study Says 2Health News:Lawson researchers engineer a switch to tame aggressive cancers 2Health News:Rutgers study finds paid family leave leads to positive economic outcomes 2Health News:Rutgers study finds paid family leave leads to positive economic outcomes 3
... Administration Control System, provides the healthcare ... are administering the correct medication to ... bar coded patient bracelet and a ... of the hospital's pharmacy system to ...
... administration, any error is one you simply ... the Dynamic Hospital AdministratOR. This powerful application ... suitable for hospitals of all sizes. It ... as a fully-integrated component of existing systems. ...
... that support the nursing process. The caregiver ... I&O information at the point of collection ... This design supports compliance with documentation requirements., ... at the nursing station, wCareAssist™ is right ...
... critical information to the patient's unique bar-coded identifier for accurate, easy recording of tests, diagnosis and care. ... ... ... Patient LinkUp™ Enterprise (PLUE) ...
Medicine Products: